Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| TTS-2404-65126 | Other Grant/Funding Number | Grand Challenges Canada | |
| 000544699 | Other Identifier | UAB OSP |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Teaching Hospital, Lusaka, Zambia | OTHER |
| University of Zambia | OTHER |
| University of Cincinnati | OTHER |
| Centre for Infectious Disease Research in Zambia |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to learn if extended admission to the Kangaroo Mother Care (KMC) ward helps to prevent postpartum depression in mothers of low birthweight infants in a low-resource setting whose newborns were admitted to the neonatal intensive care unit (NICU) more than standard of care KMC. The main questions it aims to answer are:
Researchers will compare (extended admission to the KMC ward) to (standard of care KMC) to see if extended KMC decreases PPD in mothers of preterm infants in low-resource settings.
Participants (infants) will:
The overarching objective is to determine whether initiation of Kangaroo Mother Care (KMC) at the neonatal intensive care unit (NICU) followed by admission to the KMC ward for continued support for more than 2 days before discharge home reduces maternal postpartum depression (PPD) and other maternal and infant adverse outcomes in low-resource settings. The central hypothesis is that NICU KMC plus admission of mother-infant (preterm) dyads to the KMC ward following NICU discharge for more than 2 days will reduce the risk of maternal PPD as compared to NICU KMC followed by admission of the mother-infant dyad to the KMC ward for up to 2 days only.
The study aims are:
Aim 1: To determine the effect of admission of mother-infant dyads to the KMC Ward following NICU for more than 2 days on maternal PPD at 2 weeks, 6-8 weeks, 6 months, and 12 months.
Aim 2: To determine the effect of admission of mother-infant dyads to the KMC Ward for more than 2 days on infants' developmental outcomes at 6-,12-, and 18 months of age.
Aim 3: To characterize the feasibility and barriers to uptake of KMC at the hospital and following discharge from the perspective of parents and other family members.
Aim 4: To determine the prevalence of paternal depression.
Aim 5: To estimate the cost and effectiveness of admission of low birthweight infants to the KMC ward.
Study design This study is a randomized controlled trial of newly delivered women whose preterm newborns have been admitted to the neonatal intensive care unit (NICU) with admission to the Kangaroo Mother Care (KMC) ward for up to 2 days (control) or with admission to the KMC ward for more than 2 days (intervention) prior to discharge home. The study will enroll a total of 1908 study participants from both study arms pulled from 612 mothers (aim #1), 612 infants (aim #2), 72 participants for in-depth interviews (aim #3), and 612 fathers (aim #4).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Admission to Kangaroo Mother Care (KMC) ward for > 2 days after discharge from NICU | Experimental | Following discharge from the neonatal intensive care unit (NICU), preterm mothers and their infants will be discharged to an inpatient kangaroo mother care (KMC) ward for greater than 2 days for continued support. |
|
| Admission to Kangaroo Mother Care (KMC) ward for < 2 days after discharge from NICU | Placebo Comparator | Following discharge from the neonatal intensive care unit (NICU), preterm mothers and their infants will be discharged to an inpatient kangaroo mother care (KMC) ward for less than 2 days for continued support. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Kangaroo mother care (KMC) support for > 2 days | Behavioral | Admission to the kangaroo mother care (KMC) ward with continued support of kangaroo mother care, breastfeeding, and preterm infant care for greater than 2 days prior to discharge home |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Mothers with Postpartum Depression (PPD) | Score on Edinburgh Postnatal Depression Scale (EPDS) screening tool obtained by interview with mother. This screening tool is a 10-question tool validated for use among pregnant women in low resource countries. It can be used for screening of perinatal depression, beginning from antenatal period up to 6-8 weeks postnatal age. Each question is scored between 0-3, the highest cumulative score being 30. Cut-off score for mothers with suspected postpartum depression (PPD) will be 11. All mothers who screen 11+ will be categorized to have PPD, all mothers scoring below 11 will be categorized as negative for PPD. | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Mothers with Postpartum Depression (PPD) | Score on Edinburgh Postnatal Depression Scale (EPDS) screening tool obtained by interview with mother. This screening tool is a 10-question tool validated for use among pregnant women in low resource countries. It can be used for screening of perinatal depression, beginning from antenatal period up to 6-8 weeks postnatal age. Each question is scored between 0-3, the highest cumulative score being 30. Cut-off score for mothers with suspected postpartum depression (PPD) will be 11. All mothers who screen 11+ will be categorized to have PPD, all mothers scoring below 11 will be categorized as negative for PPD. |
Not provided
Inclusion Criteria:
-AIM #1-2 and #5
Mothers to newborns who are:
1) Birthweight between 1000-2000gm 2) Admitted to the Women and Neonates Hospital-University Teaching Hospital Neonatal Intensive Care Unit (WNH-UTH NICU) (>48hrs) 3) Stable preterm eligible for continuing kangaroo mother care (KMC) in the NICU or NICU discharge 4) 16+ years of age (Mother) 5) Residing within Lusaka Province with no intensions to relocate in the coming 18 months
AIM #3
AIM # 4:
Exclusion Criteria:
AIM #1-2 and #5
AIM #3
1) Family members of parents who do not consent to study participation
AIM # 4:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Albert Manasyan, MD, MPH | Contact | +260976448994 | albert.manasyan@cidrz.org | |
| J.Anitha Menon, MA, PhD | Contact | +260977846116 | AnithaMenon316@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Albert Manasyan, MD, MPH | Centre for Infectious Disease Research in Zambia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Women and Newborn Hospital - University Teaching Hospitals | Recruiting | Lusaka | 10101 | Zambia |
De-identified individual participant data underlying the results reported in the primary publication, including maternal, paternal, and infant demographic characteristics, baseline maternal and paternal psychosocial variables, validated postpartum depression assessment scores, randomized intervention allocation, follow-up maternal and paternal mental health outcomes, relevant neonatal clinical variables collected as part of the study, and neurodevelopmental screening data of the infant.
All direct identifiers will be removed. Indirect identifiers will be coded or aggregated to minimize re-identification risk in accordance with ethical and regulatory requirements in Zambia.
Data will be made available beginning 12 months following publication of the primary study results and will remain available for up to 5 years after publication.
Data will be available to qualified researchers who submit a scientifically sound research proposal consistent with the objectives of the original study and compliant with ethical standards.
Access will require:
Data will be shared through a secure data transfer platform or controlled-access repository.
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
|
| Kangaroo mother care (KMC) support for < 2 days | Behavioral | Admission to the kangaroo mother care (KMC) ward with continued support of kangaroo mother care, breastfeeding, and preterm infant care for less than 2 days prior to discharge home |
|
|
| 2 weeks, 6 months, 12 months |
| Hours spent practicing Kangaroo Mother Care (KMC) in the neonatal intensive care unit (NICU) | Time in hours and minutes spent practicing kangaroo mother care (KMC) per day by the mother obtained by interview with mother. | 2 weeks |
| Hours spent practicing Kangaroo Mother Care (KMC) in the KMC Ward | Time in hours and minutes spent practicing kangaroo mother care (KMC) per day by the mother obtained by interview with mother. | 2 weeks |
| Hours spent practicing Kangaroo Mother Care (KMC) at home | Time in hours and minutes spent practicing kangaroo mother care (KMC) per day by the mother obtained by interview with mother. | 2 weeks, 8 weeks, 6 months, 12 months |
| Time of initiation of breastfeeding | Time in hours and minutes after delivery, when infant is initially put to breast for feeding | 2 weeks |
| Number of months breastfeeding | Number of months of any breastfeeding reported by the mother in an interview | 8 weeks, 6 months, 12 months |
| Number of barriers to kangaroo mother care (KMC) initiation at the birth hospital | A pre-defined set of questions will be asked to all the mothers to determine the barriers contributing to kangaroo mother care (KMC) initiation at the birth hospital. The Investigators will enroll mothers (n=24), fathers (n=24), and family members (n=24) to undergo in-depth interviews (IDIs). | 12 months |
| Number of barriers to kangaroo mother care (KMC) initiation at home | A pre-defined set of questions will be asked to all the mothers to determine the barriers contributing to kangaroo mother care (KMC) initiation at home. The Investigators will enroll mothers (n=24), fathers (n=24), and family members (n=24) to undergo in-depth interviews (IDIs). | 12 months |
| Average Infant/child developmental assessment | Score on "Ages and Stages Questionnaire" (ASQ) obtained by interview with parent developmental assessment tools which scores items (Y = 10, Sometimes = 5, Not Yet = 0) in areas of Communication, Gross motor, Fine Motor, Problem Solving and Personal-Social. Scoring of items are totaled and placed on a graph indicating cut off score. If score is above cut-off, the child's development appears to be on schedule; near the cutoff, may provide learning activities and monitor; and below cutoff, requiring further assessment. 6-month cutoffs (Communication 29.65; Gross Motor 22.25; Fine Motor 25.14; Problem Solving 27.72 and Personal-Social 25.34); 12-month cutoffs (Communication 15.64; Gross Motor 21.49; Fine Motor 34.50; Problem Solving 27.32 and Personal-Social 21.73); 18-month cutoffs (Communication 13.06; Gross Motor 37.38; Fine Motor 34.32; Problem Solving 25.74 and Personal-Social 27.19). | 6 months,12 months, 18 months |
| Average weight in grams | Weight in grams, weighed on a digital scale | birth, up to 8 weeks, 6 months, 12 months, 18 months |
| Average length in centimeters (cm) | Length in centimeters, top of head to heel, measured with paper tape measure | birth, up to 8 weeks, 6 months, 12 months, 18 months |
| Average head Circumference in centimeters (cm) | Head Circumference in centimeters (cm), occipital-frontal, measured with paper tape measure | birth, up to 8 weeks, 6 months, 12 months, 18 months |
| Percentage of all cause 28-day neonatal mortality | Report of neonatal vital status within 28 days, obtained in maternal interview | 28 days |
| Percentage of neonatal morbidity | Report of neonatal health status, obtained in maternal interview (e.g., neonatal sepsis, diarrhoea, breathing difficulties) | 28 days |
| Percentage of infant readmission to facility | Neonatal rehospitalization after initial discharge from the hospital assessed by maternal interview or medical records documentation | 18 months |
| Percentage of infant mortality | Documentation of or report of infant death, assessed through medical records or maternal interview | 18 months |
| Percentage of infant morbidity | Report of infant morbidity, assessed through maternal interview (e.g., diarrhoea, pneumonia, sepsis, respiratory infections) | 18 months |
| Percentage of vaccine adherence | Report of infant's adherence to the required vaccinations per national guidelines in Zambia through maternal interview - Bacille Calmette-Guérin (BCG) - at birth Polio (Oral Polio Virus 0, 1, 2, 3) - birth, 6, 10, and 14 weeks Diphtheria, tetanus, whooping cough (pertussis) or DTP, polio, hepatitis B and Haemophilus influenzae type b (Hib) - DPT-HepB-HiiB (1, 2, 3) - at 6, 10, and 14 weeks Measles - at 9 and 18 months Rotavirus 1, 2 - at 6 and 14 weeks Preumococcal Vaccine (PCV) 1, 2 - at 6, 10, and 14 weeks | 12 months |
| Number of barriers to practicing kangaroo mother care (KMC() at the hospital | A pre-defined set of questions will be asked to determine the barriers contributing to practicing kangaroo mother care (KMC) initiation at the hospital. The Investigators will enroll mothers (n=24), fathers (n=24), and family members (n=24) to undergo in-depth interviews (IDIs). | 12 months |
| Number of facilitators to practicing kangaroo mother care (KMC) at the hospital | A pre-defined set of questions will be asked to determine the facilitators contributing to practicing kangaroo mother care (KMC) initiation at the hospital. The Investigators will enroll mothers (n=24), fathers (n=24), and family members (n=24) to undergo in-depth interviews (IDIs). | 12 months |
| Number of barriers to practicing kangaroo mother care (KMC) at home | A pre-defined set of questions will be asked to determine the barriers contributing to practicing kangaroo mother care (KMC) initiation at home. The Investigators will enroll mothers (n=24), fathers (n=24), and family members (n=24) to undergo in-depth interviews (IDIs). | 12 months |
| Number of facilitators to practicing kangaroo mother care (KMC) at home | A pre-defined set of questions will be asked to all the mothers to determine the facilitators contributing to practicing kangaroo mother care (KMC) initiation at home. The Investigators will enroll mothers (n=24), fathers (n=24), and family members (n=24) to undergo in-depth interviews (IDIs). | 12 months |
| Percentage of fathers with postpartum depression | Score on Edinburg Postnatal Depression Scale (EPDS) screening tool obtained by interview with mother. This screening tool is a 10-question tool validated for use among pregnant women in low resource countries. It can be used for screening of perinatal depression, beginning from antenatal period up to 6-8 weeks postnatal age. Each question is scored between 0-3, the highest cumulative score being 30. Cut-off score for fathers with suspected postpartum depression (PPD) will be 9. All fathers who screen 9+ will be categorized to have PPD, all fathers scoring below 9 will be categorized as negative for PPD. | 2 weeks, 8 weeks, 6 months, 12 months |
| Hours of time father spent with newborn daily | Time (hours/minutes) spent interacting with the newborn/infant each day obtained by interview with the father | 8 weeks, 6 months, 12 months |
| Percentage of mothers with depression | Patient Health Questionnaire (PHQ-9) is a 9-question patient-administered screening tool for the assessment of depression among mothers and fathers. Since PHQ-9 can be used repeatedly to monitor depressive symptoms among the same patient/study participant, it will be used at different time points throughout the study. The severity scale is as follows:
| 2 weeks, 8 weeks, 6 months, and 12 months |
| Percentage of mothers with self-reported perceived social support | Multidimensional Scale of Perceived Social Support (MSPSS) is a tool for screening of perceived social support from family, friends, and significant other.] It, a brief and easy-to-follow self-report measure, is a 12-question tool using a 5-point Likert scale (0 = strongly disagree, 5 = strongly agree). It uses positive and negative phrasing to limit response set bias of agreement. Mothers enrolled in the study will be screened using the MSPSS screening tool at 6 and 12 months following enrolment. This total score can also be calculated as a mean score (divide by 12). To calculate the mean subscale scores:
Scores are divided into:
| 6 months, 12 months |
| Cost of admission to kangaroo mother care (KMC) ward | Government funds spent by the government for admission of one newborn to the kangaroo mother care (KMC) ward per day obtained from government sources. This will estimate the average cost per patient admitted to the KMC ward. | Through KMC discharge of up to 8 weeks |
| Cost of readmission to the neonatal intensive care unit (NICU) | Funds spent by the government for readmission of one newborn to the neonatal intensive care unit (NICU) per day obtained from government sources. This will estimate the average cost per patient admitted to the NICU. | Through NICU discharge of up to 8 weeks |
| Cost associated with hospital readmissions | Funds spent by the government for readmission of one infant to the hospital per day obtained from government sources. This will estimate the average cost per patient readmitted to the hospital. | 12 months |
| Out-of-pocket family costs associated with hospital readmissions | Funds spent by the family associated with readmission of one infant to the hospital per day obtained from maternal interview. This will estimate the average funds spent by the family per patient readmitted to the hospital. | 12 months |
| ID | Term |
|---|---|
| D019052 | Depression, Postpartum |
| D047928 | Premature Birth |
| ID | Term |
|---|---|
| D011644 | Puerperal Disorders |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
| D007752 | Obstetric Labor, Premature |
| D007744 | Obstetric Labor Complications |
Not provided
Not provided
| ID | Term |
|---|---|
| D060127 | Kangaroo-Mother Care Method |
| D010166 | Palliative Care |
| ID | Term |
|---|---|
| D056888 | Patient Positioning |
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D007224 | Infant Care |
| D002654 | Child Care |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided